EUVIMEDEUVIMED entdecken
Crossref

Connectomics and neurotransmitter receptor profile explain regional tau pathology in Alzheimer’s disease

Fardin Nabizadeh iD, Alzheimer’s Disease Neuroimaging Initiative

Cerebral Cortex · 2025

DOI: 10.1093/cercor/bhaf053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebral Cortex, 2025. Verfasst von Fardin Nabizadeh und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptors, Neurotransmitter, tau Proteins, Connectome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease tau pathology spreads through neuronal pathways and synaptic connections. Alteration in synaptic activity facilitates tau spreading. Multiple neurotransmitter systems are shown to be implicated in Alzheimer’s disease, but their influence on the trans-synaptic spread of tau is not well understood. I aimed to combine resting-state functional magnetic resonance imaging connectomics, neurotransmitter receptor profiles, and tau-PET data to explain the regional susceptibility to tau accumulation. The tau-PET imaging data of 161 amyloid-beta-negative cognitively unimpaired participants as control and 259 amyloid-beta-positive subjects were recruited from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Linear regression analysis revealed that a higher tau-PET z-score is associated with a lower density of nine receptors in the serotonin, dopamine, gamma-aminobutyric acid (GABA), acetylcholine, and glutamate systems. Furthermore, adding four neurotransmitter receptor density z-scores significantly increased the proportion of explained variance by 3% to 7% compared to the epicenter-connectivity distance model in the group-level analysis. Also, adding nine neurotransmitter receptor density z-scores to the epicenter-connectivity distance model increased the explanatory power of variability in individual levels of tau-PET z-score by 3% to 8%. The current study demonstrated the additive value of atlas-based neurotransmitter receptor mapping and individual-level amyloid-beta-PET scans to enhance the connectivity-based explanation of tau accumulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseReceptors, Neurotransmittertau ProteinsConnectomeBrainHumansMaleFemaleAgedPositron-Emission TomographyMagnetic Resonance ImagingAged, 80 and overMiddle AgedAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer’s diseaseconnectivityneurotransmitter receptorstau

Substanzen

Receptors, Neurotransmittertau ProteinsAmyloid beta-Peptides

Autor:innen und Institutionen

ORCID-Profile: Fardin Nabizadeh

Zitieren

APA

Nabizadeh, F., & Alzheimer’s Disease Neuroimaging Initiative (2025). Connectomics and neurotransmitter receptor profile explain regional tau pathology in Alzheimer’s disease. Cerebral Cortex. https://doi.org/10.1093/cercor/bhaf053

Vancouver

Nabizadeh F, Alzheimer’s Disease Neuroimaging Initiative. Connectomics and neurotransmitter receptor profile explain regional tau pathology in Alzheimer’s disease. Cerebral Cortex. 2025. doi:10.1093/cercor/bhaf053

BibTeX
@article{Nabizadeh2025,
  author = {Nabizadeh, Fardin and Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Neuroimaging Initiative},
  title = {Connectomics and neurotransmitter receptor profile explain regional tau pathology in Alzheimer’s disease},
  journal = {Cerebral Cortex},
  year = {2025},
  doi = {10.1093/cercor/bhaf053}
}
Kostenlos starten →